Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(20%)

Phase Distribution

Ph phase_1
5
100%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Terminated(1)
Other(3)

Detailed Status

unknown3
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 15 (100.0%)

Trials by Status

unknown360%
terminated120%
not_yet_recruiting120%

Recent Activity

0 active trials
Showing 5 of 5
terminatedphase_1

A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)

NCT06245941
not_yet_recruitingphase_1

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

NCT06211751
unknownphase_1

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

NCT06165822
unknownphase_1

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

NCT05775575
unknownphase_1

A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

NCT04975204

Clinical Trials (5)

Showing 5 of 5 trials
NCT06245941Phase 1

A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)

Terminated
NCT06211751Phase 1

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

Not Yet Recruiting
NCT06165822Phase 1

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Unknown
NCT05775575Phase 1

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

Unknown
NCT04975204Phase 1

A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5